Navigation Links
OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease
Date:9/23/2010

WASHINGTON, Sept. 23 /PRNewswire/ -- OrbusNeich today announced that six-month follow-up clinical trial data demonstrate the excellent safety profile and efficacy of the company's Genous Bio-engineered R stent in combination with a paclitaxel-coated balloon for the treatment of de novo coronary artery disease. The data were presented by Jochen Woehrle, M.D., University of Ulm, Germany, principal investigator of the study, in the first report clinical trial session at Transcatheter Cardiovascular Therapeutics (TCT) 2010 in Washington.

The PERfECT STENT (A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients Treated with Endothelial Progenitor Cell Capturing Stents for De Novo Coronary Artery Disease) study compared the combination of a paclitaxel-coated balloon (SeQuent® Please, B. Braun) with a Genous stent to the Genous stent alone in 120 patients undergoing percutaneous coronary intervention (PCI).

The primary endpoint of the study was in-stent late loss at six months. Secondary endpoints included diameter stenosis, binary restenosis rate, target lesion revascularization (TLR), major adverse cardiac events (MACE) and stent thrombosis.

The in-stent late loss at six months follow-up of 0.34 mm was significantly lower in the patient group treated with the Genous stent in combination with a paclitaxel-coated balloon when compared to 0.88 mm in the control group. There was no definite and probable stent thrombosis reported in either arm of the study. Both patient groups received three months of dual antiplatelet therapy. In addition, the rates of TLR and MACE were lower in the investigational group compared to the control group.

"We are very encouraged by the good clinical and safety outcomes seen in patients treated with a combination of a paclitaxel-coated balloon and pro-healing technologies with only three months of dual antiplatelet therapy," said Professor Woehrle. "This study supports the company
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. 100 Percent Coverage of Struts and Complete Neointimal Coverage of OrbusNeichs Genous™ Bio-engineered R stent™ Demonstrated 26 Days Post-Implantation in STEMI Patient
2. Data Show OrbusNeichs Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon
3. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients
4. Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
5. OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
6. Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) in Challenging Patient Subsets
7. Pre-clinical Data Show OrbusNeichs Combo Bio-engineered Sirolimus Eluting Stent May Offer Advantages to Current Drug Eluting Stent Technologies
8. Data From Multiple Clinical Trials of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009
9. Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents
10. Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
11. Data From Multiple Clinical Trials of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... MUNICH , May 22, 2013 JenaValve ... transcatheter aortic valve implantation (TAVI) systems for the treatment of ... the J enaValve Eval U ation of Long Term ... ients with S E vere Ao R tic Stenosis (JUPITER) ... is a post-market registry to evaluate five-year long term safety ...
(Date:5/22/2013)... , May 22, 2013 The new ... safe as the previous version used prior to 2010, ... Kaiser Permanente study published today in Vaccine. ... use beginning in 2010 after a series of trials. ... broader range of pneumococcal types than the previously used ...
(Date:5/22/2013)... Jersey , 22. Mai 2013 /PRNewswire/ ... Fähigkeitsentwicklung und Beratung, gab heute bekannt, dass ... Chris Geraghty , zum Hauptgeschäftsführer ernannt ... Jahre im Industriebereich wo er zahlreiche Führungspositionen ... von Ray Baxter an, der als Kepner-Tregoe ...
Breaking Medicine Technology:First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3
... Feb. 2 The Robert C. Gallo Foundation ... appointment of Franco Nuschese as director of international ... his colleagues, who are internationally known for expertise ... also supports other organizations producing groundbreaking HIV research."It ...
... (NYSE: KR ) said today it is recalling ... in its family of stores because the products have the ... names in the 31 states where Kroger operates are included ... Less, Fry,s, King Soopers, Smith,s, Dillons, QFC, City Market, Foods ...
Cached Medicine Technology:Franco Nuschese Tapped by Robert C. Gallo Foundation for AIDS and Virus Research 2Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk 2Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk 3
(Date:5/22/2013)... May 22, 2013 Unknown to the citizens ... at 30 mph. Minutes before it struck, the city’s ... nearing threat. This gave them time to reach safety and ... is proud to provide a product that will increase ... Wheelock SAFEPATH® SP40S Emergency Evacuation System provides employees ...
(Date:5/22/2013)... May 22 (HealthDay News) -- In the aftermath of this ... struggling to care for children and relatives, but also their ... during a natural disaster and relocating to temporary housing can ... offering a few tips on how to ease that transition. ... with your pet that can be used to help identify ...
(Date:5/22/2013)... at Massachusetts General Hospital (MGH) one of the ... half rated the training they had received in addiction ... Significant numbers felt unprepared to diagnose or treat such ... response to the findings, recently published online in the ... residents, training in addiction medicine. , "Our residents ...
(Date:5/22/2013)... study suggests that disturbed sleep in adolescents is ... uncertainly about future success. However, perceived support ... have a protective effect. , Results show ... mood and greater uncertainty about future success. Higher ... teachers were associated with significantly fewer sleep disruptions ...
(Date:5/22/2013)... The newest member of TeethWhiteningforFree.com is ... of Alabama graduate, Dr. Sanderson provides professional dental care ... dentist, he extends complimentary teeth whitening to his patients ... check up. Only a dental professional can decide if ... treatments. , Teeth whitening is an easy ...
Breaking Medicine News(10 mins):Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2Health News:Simple Steps Can Protect Pets in Weather Disasters 2Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4Health News:Parent and teacher support protects teens from sleep problems and depression 2Health News:Dr. James Sanderson, Jr. Of SanDentistry in Hoover, Alabama Joins the TeethWhiteningforFree.com Family 2
... CBaySystems named to Deloitte,s Technology Fast 50 List for Maryland for a ... ... companies., ANNAPOLIS, Md., Oct. 8 CBaySystems ... prestigious,Technology Fast 50 Program for Maryland, a ranking of the 50 fastest,growing ...
... women more frequently take more of the life-prolonging supplemental ... women. , African-Americans whose cancer had spread to ... cancer therapy than white women, the study showed. Adjuvant ... in addition to the primary therapy. Studies suggest adjuvant ...
... Men From 46 States and 7 ... ... this,weekend,s fifth annual Avon Walk for Breast Cancer New York raised $10.2,million ... At,today,s Closing Ceremony at Hudson River Park,s Pier 84, Avon Foundation,Executive Director ...
... fall, study finds , SUNDAY, Oct. 7 (HealthDay News) -- ... have a better chance of survival than those diagnosed in ... suggests. , "Summer and autumn months correspond to times when ... not prove vitamin D is the determining factor, it does ...
... fibrosis is linked to MRI exposure, scientists say , ... with a newly identified disease called nephrogenic systemic fibrosis ... report. , The researchers also concluded that exposure to ... a significant risk factor for developing NSF, a painful ...
... SACRAMENTO, Calif., Oct. 5 Several medical groups,affiliated ... as tops in,quality by the independent and highly ... (IHA). The recognition is part,of the IHA,s annual ... medical groups recognized for top performance are,Solano Regional ...
Cached Medicine News:Health News:CBaySystems Selected to Receive Deloitte's 2007 Maryland Technology Fast 50 Award 2Health News:CBaySystems Selected to Receive Deloitte's 2007 Maryland Technology Fast 50 Award 3Health News:Whites take supplemental breast cancer therapy more often than blacks 2Health News:Fifth Annual Avon Walk for Breast Cancer New York Raises $10.2 Million 2Health News:Fifth Annual Avon Walk for Breast Cancer New York Raises $10.2 Million 3Health News:Prostate Cancer Survival Varies by Season 2Health News:New Kidney Disease Can Be Fatal 2Health News:Sutter Health Medical Groups Among the Best for Health Care Quality 2
... the highest g-force ever. But optimal productivity ... Optima MAX combines maximum force, capacity, and ... that's worlds apart from any other system. ... enhanced efficiency, Optima takes productivity to the ...
... generating 694,000 x g at ... Beckman Coulter's Optima L-90K Ultracentrifuge ... separations in less time. This ... a broad range of superb ...
... With the ability to provide a simple, ... in lipemic samples), the Airfuge CLS delivers ... can be cleaned in 10 minutes, eliminating ... tabletop centrifuge: Reaches top speed in as ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
Medicine Products: